Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care

In this online program centered around a dynamic CCO symposium in Orlando experts discuss recent advances in the management of essential thrombocythemia polycythemia vera and myelofibrosis. Watch the on-demand Webcast and download the slides from the symposium and read expert commentaries on current and emerging therapeutic strategies for patients with MPNs.

Share

Program Content

No activities added yet

Activities

MF After Ruxolitinib
Managing Patients With Myelofibrosis Following Ruxolitinib Failure
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 07, 2019

Expires: October 05, 2020

ASH 2019: MPNs
ASH 2019 Preview: Key Expert-Selected MPN Studies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 02, 2019

Expires: November 30, 2020

FAQ: MPNs
Experts Answer Frequently Asked Questions on the Management of Myeloproliferative Neoplasms
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 16, 2020

Expires: January 14, 2021

Activities

MPN Diagnosis
MPN Driver Mutations, Diagnosis, and Risk Stratification
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

Myelofibrosis Management
Contemporary Management of Myelofibrosis
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

Myelofibrosis: Emerging Therapies
Myelofibrosis: Emerging Therapeutic Strategies and Managing Patients Intolerant/Resistant to Ruxolitinib
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

PV and ET
Polycythemia Vera and Essential Thrombocythemia in Focus
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Celgene

CTI BioPharma Corp., a Sobi Company

Geron